Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTNNB1 | P35222 | 6/20 | 0.65 |
| ▸ | WNT3A | P56704 | 6/20 | 0.65 |
| ▸ | RAB9A | P51151 | 3/20 | 0.55 |
| ▸ | NPC1 | O15118 | 2/20 | 0.55 |
| ▸ | JAK2 | O60674 | 1/20 | 0.55 |
| ▸ | MAOB | P27338 | 3/20 | 0.54 |
| ▸ | ROCK2 | O75116 | 4/20 | 0.53 |
| ▸ | ROCK1 | Q13464 | 4/20 | 0.53 |
| ▸ | CLK2 | P49760 | 2/20 | 0.52 |
| ▸ | DYRK1A | Q13627 | 2/20 | 0.52 |
| ▸ | CLK4 | Q9HAZ1 | 2/20 | 0.52 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.52 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.52 |
| ▸ | RPS6KB1 | P23443 | 1/20 | 0.52 |
| ▸ | PRKG1 | Q13976 | 1/20 | 0.52 |
| ▸ | PRKD2 | Q9BZL6 | 1/20 | 0.52 |
| ▸ | SGK2 | Q9HBY8 | 1/20 | 0.52 |
| ▸ | STK17A | Q9UEE5 | 1/20 | 0.52 |
| ▸ | NOS1 | P29475 | 3/20 | 0.52 |
| ▸ | METAP2 | P50579 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30270547 | 1.00 | CTNNB1 (0.65) | CTNNB1WNT3ARAB9ANPC1JAK2 | |
| Hydrochloric Acid SCHEMBL1665151 | 0.98 | CTNNB1 (0.63) | CTNNB1WNT3ARAB9ANPC1JAK2 | |
| Trifluoroacetic Acid SCHEMBL27736715 | 0.91 | CTNNB1 (0.56) | CTNNB1WNT3ARAB9ANPC1JAK2 | |
| SCHEMBL31253099 | 0.86 | GSK3B (0.68) | CTNNB1WNT3ARAB9ANPC1JAK2 | |
| SCHEMBL23063810 | 0.86 | GSK3B (0.68) | CTNNB1WNT3ARAB9ANPC1JAK2 | |
| SCHEMBL260992 | 0.85 | ALDH1A1 (0.56) | CTNNB1WNT3AMAOBCLK2DYRK1A | |
| SCHEMBL29365815 | 0.85 | ALDH1A1 (0.56) | CTNNB1WNT3AMAOBCLK2DYRK1A | |
| SCHEMBL1419814 | 0.84 | AR (0.63) | CTNNB1WNT3ARAB9ANPC1JAK2 | |
| SCHEMBL20187077 | 0.84 | CTNNB1 (0.59) | CTNNB1WNT3ARAB9ANPC1JAK2 | |
| Hydrochloric Acid SCHEMBL7001071 | 0.84 | ALDH1A1 (0.55) | CTNNB1WNT3AMAOBCLK2DYRK1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 629 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122036615-A | Indazole hydrazide compound and preparation method and application thereof | 南京农业大学 | 2026-05-15 | — | — | CN | claimed |
| CN-119285974-A | Zinc-based metal organic framework material and preparation method and application thereof | 北京化工大学 | 2025-01-10 | — | — | CN | claimed |
| CN-117696012-A | Metal organic framework material and preparation method and application thereof | 浙江大学 | 2024-03-15 | — | — | CN | claimed |
| CN-117050300-A | Polylysine-based polymer adjuvant material, and preparation method and application thereof | 中国科学院长春应用化学研究所 | 2023-11-14 | — | — | CN | claimed |
| CN-113603886-A | Polyethyleneimine derivative and preparation method and application thereof | 中国科学院长春应用化学研究所 | 2021-11-05 | — | — | CN | claimed |
| EP-3288940-B9 | AZABENZIMIDAZOLES AND THEIR USE AS AMPA RECEPTOR MODULATORS | JANSSEN PHARMACEUTICA NV (BE) | 2021-07-21 | — | — | EP | claimed |
| EP-3288940-B1 | AZABENZIMIDAZOLES AND THEIR USE AS AMPA RECEPTOR MODULATORS | JANSSEN PHARMACEUTICA NV (BE) | 2021-02-24 | — | — | EP | claimed |
| US-10604493-B2 | Compositions, methods of use, and methods of treatment | UNIVERSITY OF SOUTH FLORIDA (US) | 2020-03-31 | — | — | US | claimed |
| US-7674795-B2 | Fluorene derivatives, composition containing said derivatives and the use thereof | AVENTIS PHARMA SA (FR) | 2010-03-09 | — | — | US | claimed |
| EP-1628972-B1 | INDAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS | SANOFI AVENTIS DEUTSCHLAND (DE) | 2009-04-22 | — | — | EP | claimed |
| US-20080153837-A1 | Novel Fluorene Derivatives, Composition Containing Said Derivatives and the Use Thereof | AVENTIS PHARMA S.A. (FR) | 2008-06-26 | — | — | US | claimed |
| CN-1200110-C | Method of preparing non protein source L-amino acid | INTERNAT ELECTROMECHANICAL IND (DE) | 2005-05-04 | — | — | CN | claimed |
| US-6579705-B2 | Generating preferential amino acid sequences; obtain adjusted amino acid, incubate with enzyme, recover amino acid | CONSORTIUM FUR ELEKTROCHEMISCHE INDUSTRIE GMBH (DE) | 2003-06-17 | — | — | US | claimed |
| US-20020177196-A1 | Process for preparing non-proteinogenic L-amino acids | CONSORTIUM FUR ELEKTROCHEMISCHE INDUSTRIE GMBH | 2002-11-28 | — | — | US | claimed |
| CN-1379111-A | Method of preparing non protein source L-amino acid | INTERNAT ELECTROCHEMICAL INDUS (DE) | 2002-11-13 | — | — | CN | claimed |
| EP-1247869-A1 | Process for the production of non-proteinogenic amino acids | Consortium für elektrochemische Industrie GmbH (DE) | 2002-10-09 | — | — | EP | claimed |
| JP-11228513-A | — | — | None | — | — | JP | disclosed |
| CN-122036615-A | Indazole hydrazide compound and preparation method and application thereof | 南京农业大学 | 2026-05-15 | — | — | CN | disclosed |
| JP-H11228513-A | 4-ACETYLAMINO-3-METHYLBENZOIC ACID COMPOUND, ITS PRODUCTION AND PRODUCTION OF 1H-INDAZOLE-5-CARBOXYLIC ACID USING THE SAME | SUMIKA FINE CHEMICALS CO LTD | 1999-08-24 | — | — | JP | disclosed |
| EP-0573218-A2 | 4-Carboxyimidazoles as angiotensin II antagonists and their thrapeutic use | SANKYO COMPANY LIMITED (JP) | 1993-12-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10604493-B2 | Compositions, methods of use, and methods of treatment | LIPA, LCT, GAA | CTNNB1 529/4885WNT3A 2657/4885RAB9A 2492/4885 |
| US-20080153837-A1 | Novel Fluorene Derivatives, Composition Containing Said Derivatives and the Use Thereof | HSP90B1, HSP90AB1, HSP90AA1 | CTNNB1 2510/4885WNT3A 4015/4885RAB9A 1012/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.